284 related articles for article (PubMed ID: 11237863)
1. Cyclosporin A reduces canalicular membrane fluidity and regulates transporter function in rats.
Yasumiba S; Tazuma S; Ochi H; Chayama K; Kajiyama G
Biochem J; 2001 Mar; 354(Pt 3):591-6. PubMed ID: 11237863
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin overload modulates bile canalicular membrane fluidity in rats: association with disproportionate reduction of biliary lipid secretion.
Kajihara T; Tazuma S; Yamashita G; Kajiyama G
J Gastroenterol; 2000; 35(6):450-5. PubMed ID: 10864353
[TBL] [Abstract][Full Text] [Related]
3. Modifying hepatic phospholipid synthesis associates with biliary phospholipid secretion rate in a transporter-independent manner in rats: relation to canalicular membrane fluidity.
Yasumiba S; Tazuma S; Ochi H; Kajiyama G; Mdt
Dig Dis Sci; 2001 Jun; 46(6):1290-8. PubMed ID: 11414307
[TBL] [Abstract][Full Text] [Related]
4. Biliary excretory function is regulated by canalicular membrane fluidity associated with phospholipid fatty acyl chains in the bilayer: implications for the pathophysiology of cholestasis.
Hyogo H; Tazuma S; Kajiyama G
J Gastroenterol Hepatol; 2000 Aug; 15(8):887-94. PubMed ID: 11022829
[TBL] [Abstract][Full Text] [Related]
5. Bile-salt hydrophobicity is a key factor regulating rat liver plasma-membrane communication: relation to bilayer structure, fluidity and transporter expression and function.
Asamoto Y; Tazuma S; Ochi H; Chayama K; Suzuki H
Biochem J; 2001 Nov; 359(Pt 3):605-10. PubMed ID: 11672435
[TBL] [Abstract][Full Text] [Related]
6. Effect of mdr2 mutation with combined tandem disruption of canalicular glycoprotein transporters by cyclosporine A on bile formation in mice.
Elamiri A; Perwaiz S; Tuchweber B; Yousef IM
Pharmacol Res; 2003 Nov; 48(5):467-72. PubMed ID: 12967592
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of hepatic transport of cyclosporin A: an explanation for its cholestatic action?
Fricker G; Fahr A
Yale J Biol Med; 1997; 70(4):379-90. PubMed ID: 9626758
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat.
Galán AI; Román ID; Muñoz ME; Cava F; Gonzalez-Buitrago JM; Esteller A; Jimenez R
Biochem Pharmacol; 1992 Sep; 44(6):1105-13. PubMed ID: 1417934
[TBL] [Abstract][Full Text] [Related]
9. Hydrophilic bile salts have a cytoprotective effect against cyclosporine A-induced cholestasis through enhanced canalicular membrane fluidity and transporter activity.
Tsuboi K; Tazuma S; Ochi H; Chayama K
Hepatol Res; 2003 Jan; 25(1):38-47. PubMed ID: 12644037
[TBL] [Abstract][Full Text] [Related]
10. Protoporphyrin IX-induced impairment of biliary lipid secretion in the rat.
Perez-Barriocanal F; Redondo-Torres JG; Villanueva GR; Arteche E; Berenson MM; Marin JJ
Clin Sci (Lond); 1989 Nov; 77(5):473-8. PubMed ID: 2555104
[TBL] [Abstract][Full Text] [Related]
11. Transcytotic vesicle fusion is reduced in cholestatic rats: redistribution of phospholipids in the canalicular membrane.
Hyogo H; Tazuma S; Kajiyama G
Dig Dis Sci; 1999 Aug; 44(8):1662-8. PubMed ID: 10492150
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of biliary phospholipid and cholesterol secretion by organic anions affects bile canalicular membrane composition and fluidity.
Verkade HJ
J Gastroenterol; 2000; 35(6):481-5. PubMed ID: 10864360
[No Abstract] [Full Text] [Related]
13. Partial characterization of regulation of biliary lecithin hydrophobicity: association with organic anion-induced solute cholestasis in rats.
Miura H; Tazuma S; Kajiyama G
Biochem J; 1995 Dec; 312 ( Pt 3)(Pt 3):795-7. PubMed ID: 8554522
[TBL] [Abstract][Full Text] [Related]
14. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
Macias RI; Serrano MA; Monte MJ; Jimenez S; Hernandez B; Marin JJ
J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
[TBL] [Abstract][Full Text] [Related]
15. Synergistic role of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7alpha-hydroxylase in the pathogenesis of manganese-bilirubin-induced cholestasis in rats.
Akoume MY; Perwaiz S; Yousef IM; Plaa GL
Toxicol Sci; 2003 Jun; 73(2):378-85. PubMed ID: 12700418
[TBL] [Abstract][Full Text] [Related]
16. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional alterations of hepatocytes during transient phalloidin-induced cholestasis in the rat.
Loranger A; Barriault C; Yousef IM; Tuchweber B
Toxicol Appl Pharmacol; 1996 Mar; 137(1):100-11. PubMed ID: 8607135
[TBL] [Abstract][Full Text] [Related]
18. Phospholipid alterations in hepatocyte membranes and transporter protein changes in cholestatic rat model.
Hyogo H; Tazuma S; Nishioka T; Ochi H; Yamaguchi A; Numata Y; Kanno K; Sakomoto M; Asamoto Y; Tsuboi K; Nakai K; Yasumiba S; Sunami Y; Kajiyama G
Dig Dis Sci; 2001 Oct; 46(10):2089-97. PubMed ID: 11680581
[TBL] [Abstract][Full Text] [Related]
19. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
20. Alteration of lipid composition of hepatic membranes associated with manganese-bilirubin induced cholestasis.
Duguay A; Yousef IM; Tuchweber B; Plaa GL
Fundam Clin Pharmacol; 1998; 12(2):213-9. PubMed ID: 9565777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
